Comments
Loading...
Catalent (NYSE:CTLT) Stock Quotes, Forecast and News Summary
Catalent Stock (NYSE: CTLT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Catalent (CTLT) stock?
You can purchase shares of Catalent (NYSE:CTLT) through any online brokerage.
Who are Catalent (CTLT) competitors?
Other companies in Catalent’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Catalent (CTLT) stock?
Catalent has a consensus price target of $54.08.
What is the current price for Catalent (CTLT)?
The stock price for Catalent (NYSE: CTLT) is $59.32 last updated November 14, 2024 at 12:08 PM EST.
Does Catalent (CTLT) pay a dividend?
There are no upcoming dividends for Catalent.
When is Catalent (NYSE:CTLT) reporting earnings?
Catalent’s Q2 earnings are confirmed for Friday, February 7, 2025.
Is Catalent (CTLT) going to split?
There is no upcoming split for Catalent.
What sector and industry does Catalent (CTLT) operate in?
Catalent is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.